Jazz Pharmaceuticals
Clinical trials sponsored by Jazz Pharmaceuticals, explained in plain language.
-
New combo aims to keep advanced lung cancer in check
Disease control Not yet recruitingThis study tests whether a combination of two drugs (lurbinectedin and durvalumab) can help keep extensive-stage small-cell lung cancer from growing after initial chemotherapy. About 50 adults whose cancer did not worsen after first treatment will receive this maintenance therapy…
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for brain tumor patients: experimental drug targets recurrent meningioma
Disease control Not yet recruitingThis study tests an experimental drug called JZP3507 in 30 adults with recurrent grade 2 or 3 meningioma, a type of brain tumor. Participants take the drug orally to see if it can shrink or control the tumor. The goal is to find a new treatment option for people who have not resp…
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:53 UTC